Response to 'viral hepatitis guidelines for transplant recipients'.
Abbott
Kevin C
KC
D000998:Antiviral Agents / Q000627:therapeutic use; D006505:Hepatitis / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology* / Q000821:virology; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors
D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols